These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 17964347

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. New treatments for age-related macular degeneration.
    Taylor HR, Pezzullo ML, Guymer R.
    Lancet; 2007 Oct 27; 370(9597):1481. PubMed ID: 17964346
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. New treatments for age-related macular degeneration.
    Hamilton WS.
    Lancet; 2007 Oct 27; 370(9597):1480-1. PubMed ID: 17964344
    [No Abstract] [Full Text] [Related]

  • 5. The growing importance of pharmacoeconomics: the case of age-related macular degeneration.
    Smith AF.
    Br J Ophthalmol; 2010 Sep 27; 94(9):1116-7. PubMed ID: 20576774
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Anti-VEGF agents for age-related macular degeneration.
    Ozkiris A.
    Expert Opin Ther Pat; 2010 Jan 27; 20(1):103-18. PubMed ID: 20021287
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Implications of "not me" drugs for health systems: lessons from age related macular degeneration.
    Campbell RJ, Dhalla IA, Gill SS, Bell CM.
    BMJ; 2012 May 01; 344():e2941. PubMed ID: 22549055
    [No Abstract] [Full Text] [Related]

  • 14. [Age Related Macular Degeneration--a review].
    Björnsson OM, Kinge B.
    Laeknabladid; 2005 May 01; 91(7-8):591-5. PubMed ID: 16155343
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Looking beyond Lucentis on the management of macular degeneration.
    Fletcher EC, Chong NV.
    Eye (Lond); 2008 Jun 01; 22(6):742-50. PubMed ID: 18188178
    [Abstract] [Full Text] [Related]

  • 17. [New drug treatment for age-related macular degeneration].
    Stefánsson E, la Cour M, Helgadóttir G, Sigurdsson H, Jónasson F.
    Laeknabladid; 2007 Apr 01; 93(4):299-301. PubMed ID: 17460341
    [Abstract] [Full Text] [Related]

  • 18. Cystoid macular degeneration in exudative age-related macular degeneration.
    Querques G, Coscas F, Forte R, Massamba N, Sterkers M, Souied EH.
    Am J Ophthalmol; 2011 Jul 01; 152(1):100-107.e2. PubMed ID: 21570056
    [Abstract] [Full Text] [Related]

  • 19. [Avastin and Lucentis for macular degeneration].
    Nau JY.
    Rev Med Suisse; 2012 Aug 29; 8(351):1636-7. PubMed ID: 22988719
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.